CN109832298A - A kind of medical sterilization formulation - Google Patents
A kind of medical sterilization formulation Download PDFInfo
- Publication number
- CN109832298A CN109832298A CN201711221688.6A CN201711221688A CN109832298A CN 109832298 A CN109832298 A CN 109832298A CN 201711221688 A CN201711221688 A CN 201711221688A CN 109832298 A CN109832298 A CN 109832298A
- Authority
- CN
- China
- Prior art keywords
- fungicide
- parts
- activin
- biguanides
- medical sterilization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a kind of medical sterilization formulations comprising alkyl biguanides fungicide, povidone iodine, activin, carbamate and deionized water.The beneficial effects of the present invention are: component proportion is scientific and reasonable, alkyl biguanides fungicide is combined with activin and carbamate, and stability is high, have sterilizing power strong simultaneously, bactericidal range is wide, and irritation is minimum, easy cleaning, without allergic reaction, it is quick and easy and safe.
Description
Technical field
The present invention relates to a kind of fungicide more particularly to a kind of medical sterilization formulations.
Background technique
Disinfectant can be divided into bactericidal agent, high effect disinfectants, middle effect disinfectants and low effect disinfectants according to the level of its effect.
Bactericidal agent can kill all microorganisms and reach sterilizing requirement, including formaldehyde, glutaraldehyde, ethylene oxide, Peracetic acid, peroxide
Change hydrogen, chlorine dioxide and hypochlorous acid etc..High effect disinfectants are to all bacterial propagule (including mycobacteria), virus, fungies etc.
Killing rate up to 99.9999% or more, also have certain killing effect to bacterial spore.Middle effect disinfectants are only to bacterial reproduction
The rates of killing such as body, virus, fungi go out 99.9999%, to bacterial spore then without killing effect.This kind of fungicide includes disappearing containing iodine
Toxic agent, disinfectant phenolic etc..Low effect disinfectants, which can only kill bacterial propagule, virus, fungi etc., can 99.9% killing rate.This
Class disinfectant has the quaternary ammonium salts such as benzalkonium bromide, benzethonium chloride；The biguanides such as Chlorhexidine, A Xi halt, poly- hexyl biguanides；Mercury,
The metal ions class such as silver, copper；And Chinese herbal disinfectant.
Bactericidal agent, high effect disinfectants and middle effect disinfectants generally by strong oxidizing property fungicide, strong reducing property fungicide or
It is made of phenol compounds fungicide, bactericidal effect is very strong, but also has extremely strong corrosivity, irritation, toxicity and to people
The nocuity of body.If skin can be burnt into black immediately by o-phthalaldehyde and skin contact, peracetic acid etc. can immediately burn skin
It has a severe pain at white unbearably, the respiratory tract of the fungicide of class containing chlorine meeting intense stimulus people.Disinfectant phenolic can be through the skin of baby
It is absorbed with damaged wound and generates virulent property, damage the nervous system of baby, therefore be not suitable as medical article sterilizing, it is more uncomfortable
Close skin antiseptic.The metal ions class disinfectant such as mercury, silver, copper is not degradable, can pollute the environment.
On the other hand, even to efficient and middle effect disinfectants, germ is also just generating increasingly stronger drug resistance.Such as penta 2
Aldehyde has drug resistance to mycobacterium, such as Mycobacterium chelonei, people tulase, and it is contour that o-phthalaldehyde does not kill bacterial spore again
Drug resistance venereal bacteria.Disinfectant phenolic becomes the potential cause of skin infection to the comprehensive drug resistance of Gram-negative bacteria.Metal ion disappears
Toxic agent is to Pseudomonas aeruginosa, enterococcus, golden staphylococcus, pseudomonad drug resistance.Therefore market, which needs, more effectively, more easily disappears
Toxic agent comes out.
The advantages of low effect disinfectants quaternary ammonium salt and biguanides fungicide be the corrosivity to object, the pollution to environment,
Human body irritation and toxicity are smaller, but its bactericidal effect is also very low, and no matter being single use or mix to use cannot kill
Dead many strains, it is difficult to deal with the extensive popular virus occurred again and again since 21st century, such as SARS, bird flu, swine flu
Deng.
Therefore, to solve the above problems, providing a kind of new technical solution.
Summary of the invention
The present invention provides a kind of medical sterilization formulation.
The technical solution adopted by the present invention is that:
A kind of medical sterilization formulation comprising alkyl biguanides fungicide, povidone iodine, activin, carbamate and go
Ionized water.
Further, said components are respectively as follows: by weight
20-30 parts of alkyl biguanides fungicide；
5-10 parts of povidone iodine；
8-15 parts of activin；
4-7 parts of carbamate；
30-40 parts of deionized water.
Further, the alkyl biguanides fungicide is poly- hexyl methyl biguanides or alexidine.
Further, the pH value of the fungicide is 11~13.
The beneficial effects of the present invention are: component proportion is scientific and reasonable, alkyl biguanides fungicide and activin and amino first
Acid esters combines, and stability is high, while having sterilizing power strong, and bactericidal range is wide, and irritation is minimum, easy cleaning, without allergic reaction,
It is quick and easy and safe.
Specific embodiment
In order to deepen the understanding of the present invention, the present invention will be described in further detail with reference to the examples below, the embodiment
For explaining only the invention, it does not restrict the protection scope of the present invention.
Embodiment 1
A kind of medical sterilization formulation comprising alkyl biguanides fungicide, povidone iodine, activin, carbamate and go
Ionized water, said components are respectively as follows: by weight
20 parts of poly- hexyl methyl biguanides；
5 parts of povidone iodine；
8 parts of activin；
4 parts of carbamate；
30 parts of deionized water.
The pH value of fungicide is 11.
The beneficial effects of the present invention are: component proportion is scientific and reasonable, alkyl biguanides fungicide and activin and amino first
Acid esters combines, and stability is high, while having sterilizing power strong, and bactericidal range is wide, and irritation is minimum, easy cleaning, without allergic reaction,
It is quick and easy and safe.
Embodiment 2
A kind of medical sterilization formulation comprising alkyl biguanides fungicide, povidone iodine, activin, carbamate and go
Ionized water, said components are respectively as follows: by weight
25 parts of alexidine；
7 parts of povidone iodine；
12 parts of activin；
5 parts of carbamate；
35 parts of deionized water.
The pH value of fungicide is 11~12.
The beneficial effects of the present invention are: component proportion is scientific and reasonable, alkyl biguanides fungicide and activin and amino first
Acid esters combines, and stability is high, while having sterilizing power strong, and bactericidal range is wide, and irritation is minimum, easy cleaning, without allergic reaction,
It is quick and easy and safe.
Embodiment 3
A kind of medical sterilization formulation comprising alkyl biguanides fungicide, povidone iodine, activin, carbamate and go
Ionized water, said components are respectively as follows: by weight
30 parts of poly- hexyl methyl biguanides；
10 parts of povidone iodine；
15 parts of activin；
7 parts of carbamate；
40 parts of deionized water.
The pH value of fungicide is 13.
The beneficial effects of the present invention are: component proportion is scientific and reasonable, alkyl biguanides fungicide and activin and amino first
Acid esters combines, and stability is high, while having sterilizing power strong, and bactericidal range is wide, and irritation is minimum, easy cleaning, without allergic reaction,
It is quick and easy and safe.
The above described is only a preferred embodiment of the present invention, being not the limit for making any other form to the present invention
System, and made any modification or equivalent variations according to the technical essence of the invention, still fall within present invention model claimed
It encloses.
Claims (4)
1. a kind of medical sterilization formulation, it is characterised in that: it includes alkyl biguanides fungicide, povidone iodine, activin, ammonia
Carbamate and deionized water.
2. a kind of medical sterilization formulation according to claim 1, it is characterised in that: said components are distinguished by weight
Are as follows:
20-30 parts of alkyl biguanides fungicide；
5-10 parts of povidone iodine；
8-15 parts of activin；
4-7 parts of carbamate；
30-40 parts of deionized water.
3. a kind of medical sterilization formulation according to claim 1 or 2, it is characterised in that: the alkyl biguanides sterilization
Agent is poly- hexyl methyl biguanides or alexidine.
4. a kind of medical sterilization formulation according to claim 1, it is characterised in that: the pH value of the fungicide be 11~
13。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711221688.6A CN109832298A (en) | 2017-11-29 | 2017-11-29 | A kind of medical sterilization formulation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711221688.6A CN109832298A (en) | 2017-11-29 | 2017-11-29 | A kind of medical sterilization formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109832298A true CN109832298A (en) | 2019-06-04 |
Family
ID=66881720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711221688.6A Pending CN109832298A (en) | 2017-11-29 | 2017-11-29 | A kind of medical sterilization formulation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109832298A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102669141A (en) * | 2005-07-08 | 2012-09-19 | Isp投资有限公司 | Microbicidal composition |
| CN103735568A (en) * | 2013-12-19 | 2014-04-23 | 江西草珊瑚消毒用品有限公司 | Compound guanidine complex iodine skin mucosa disinfectant and preparation method thereof |
| CN104644667A (en) * | 2015-02-12 | 2015-05-27 | 天津大学 | Compound disinfectant and preparation method thereof |
| CN105126107A (en) * | 2015-09-21 | 2015-12-09 | 山东威高药业股份有限公司 | Liquid wound dressing |
| WO2016094084A1 (en) * | 2014-12-09 | 2016-06-16 | The Trustees Of Columbia University In The City Of New York | Bio-film resistant surfaces |
-
2017
- 2017-11-29 CN CN201711221688.6A patent/CN109832298A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102669141A (en) * | 2005-07-08 | 2012-09-19 | Isp投资有限公司 | Microbicidal composition |
| CN103735568A (en) * | 2013-12-19 | 2014-04-23 | 江西草珊瑚消毒用品有限公司 | Compound guanidine complex iodine skin mucosa disinfectant and preparation method thereof |
| WO2016094084A1 (en) * | 2014-12-09 | 2016-06-16 | The Trustees Of Columbia University In The City Of New York | Bio-film resistant surfaces |
| CN104644667A (en) * | 2015-02-12 | 2015-05-27 | 天津大学 | Compound disinfectant and preparation method thereof |
| CN105126107A (en) * | 2015-09-21 | 2015-12-09 | 山东威高药业股份有限公司 | Liquid wound dressing |
Non-Patent Citations (2)
| Title |
|---|
| 叶伟胜 等: "《骨质疏松内固定》", 30 September 2007, 天津科学技术出版社 * |
| 张流波 等: "《医学消毒学最新进展》", 31 December 2015, 人民军医出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gottardi et al. | N-chloramines, a promising class of well-tolerated topical anti-infectives | |
| EP3102661B1 (en) | Compositions and methods with efficacy against spores and other organisms | |
| US20070128295A1 (en) | Composition for disinfection of plants animals humans byproducts of plants and animals and articles infected with pathogens and method of producing and application of same | |
| US4814334A (en) | Composition with high bactericidal power containing a biguanide and a pyrimidine | |
| CN111802409B (en) | Broad-spectrum antiviral antibacterial disinfectant and preparation method and application thereof | |
| CN103891727A (en) | Preparation method of stable compound halogen organic disinfectant | |
| US5322856A (en) | Fortified glutaraldehyde chemical sterilant/disinfectant | |
| CN111642518A (en) | Iodophor compositions having improved stability in the presence of organic materials | |
| CN108391673A (en) | A kind of preparation method of nano silver/quaternary ammonium salt compound disinfectant | |
| CN108653121A (en) | A kind of antibacterial type disinfecting liquid containing medicinal herb components | |
| SE1650162A1 (en) | Antimicrobial and cleansing composition comprising a polymeric biguanide, EDTA, and surfactants. | |
| CN103283722A (en) | Compound disinfectant for hospital and application thereof | |
| CN109832298A (en) | A kind of medical sterilization formulation | |
| CN109832293A (en) | A kind of medical bactericide | |
| TR200101433T2 (en) | The use of phosphonoformic acid derivatives in the treatment of infections. | |
| CN104434994A (en) | Mucocutaneous disinfectant | |
| CN104523667A (en) | Combination technology for composite quaternary ammonium salt skin mucosa disinfectant | |
| CN114515255A (en) | Medical and common disinfectant for sterilization and disinfection and disinfectant wet tissue solution | |
| CN113521042A (en) | Alcohol-free wash-free virus inactivation disinfectant special for children and preparation method thereof | |
| CN113854294A (en) | Disinfectant composition for musk deer breeding houses as well as preparation method and application of disinfectant composition | |
| CN107536828A (en) | A kind of skin mucous membrane disinfectants | |
| CN107018999A (en) | A kind of mobile phone disinfection hygenic towelette gently stablized and its application | |
| KR20130123489A (en) | Microbicide compositions using vitamin b1 derivatives and effective microorganism | |
| JPH07252105A (en) | Liquid disinfectant | |
| CN110463721A (en) | A kind of antiseptic sterilization agent and preparation method thereof based on hydrogen peroxide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190604 |
|
| WD01 | Invention patent application deemed withdrawn after publication |